Timely Initiation of Targeted Therapy for NSCLC Improves Outcomes, Study Finds
Initiating targeted therapy for eligible patients with advanced non–small cell lung cancer (NSCLC) was found to improve outcomes, even when patients were started on nontargeted therapy but switched in a timely manner.
Source: ajmc.com